nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—Fluid overload—Carboplatin—uterine cancer	0.0147	0.0979	CcSEcCtD
Glycine—GLYATL1—renal system—uterine cancer	0.0121	0.0251	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—uterine cancer	0.012	1	CbGdCrCtD
Glycine—GLYAT—renal system—uterine cancer	0.0114	0.0236	CbGeAlD
Glycine—ALAS2—decidua—uterine cancer	0.00879	0.0182	CbGeAlD
Glycine—PIPOX—myometrium—uterine cancer	0.00795	0.0165	CbGeAlD
Glycine—AGXT—renal system—uterine cancer	0.00781	0.0162	CbGeAlD
Glycine—GPR18—endometrium—uterine cancer	0.00772	0.016	CbGeAlD
Glycine—GCAT—myometrium—uterine cancer	0.00771	0.016	CbGeAlD
Glycine—GCSH—renal system—uterine cancer	0.00748	0.0155	CbGeAlD
Glycine—ALAS2—female reproductive system—uterine cancer	0.00691	0.0143	CbGeAlD
Glycine—ALAS1—myometrium—uterine cancer	0.00676	0.014	CbGeAlD
Glycine—AGXT2—renal system—uterine cancer	0.00664	0.0137	CbGeAlD
Glycine—GPR18—female reproductive system—uterine cancer	0.0064	0.0132	CbGeAlD
Glycine—GLRA2—renal system—uterine cancer	0.00636	0.0132	CbGeAlD
Glycine—GLDC—decidua—uterine cancer	0.00632	0.0131	CbGeAlD
Glycine—GLDC—renal system—uterine cancer	0.0062	0.0128	CbGeAlD
Glycine—PIPOX—uterine cervix—uterine cancer	0.00619	0.0128	CbGeAlD
Glycine—GARS—myometrium—uterine cancer	0.00616	0.0127	CbGeAlD
Glycine—GLDC—endometrium—uterine cancer	0.006	0.0124	CbGeAlD
Glycine—GCSH—female reproductive system—uterine cancer	0.00599	0.0124	CbGeAlD
Glycine—PIPOX—decidua—uterine cancer	0.0059	0.0122	CbGeAlD
Glycine—GLDC—mammalian vulva—uterine cancer	0.0058	0.012	CbGeAlD
Glycine—PIPOX—renal system—uterine cancer	0.00579	0.012	CbGeAlD
Glycine—GPR18—vagina—uterine cancer	0.00578	0.012	CbGeAlD
Glycine—PIPOX—endometrium—uterine cancer	0.0056	0.0116	CbGeAlD
Glycine—GCSH—female gonad—uterine cancer	0.00545	0.0113	CbGeAlD
Glycine—GCAT—endometrium—uterine cancer	0.00543	0.0112	CbGeAlD
Glycine—PIPOX—mammalian vulva—uterine cancer	0.00541	0.0112	CbGeAlD
Glycine—SHMT2—myometrium—uterine cancer	0.00536	0.0111	CbGeAlD
Glycine—AGXT2—female reproductive system—uterine cancer	0.00532	0.011	CbGeAlD
Glycine—ALAS1—uterine cervix—uterine cancer	0.00526	0.0109	CbGeAlD
Glycine—GCAT—mammalian vulva—uterine cancer	0.00525	0.0109	CbGeAlD
Glycine—GNMT—female reproductive system—uterine cancer	0.00524	0.0108	CbGeAlD
Glycine—ALAS1—decidua—uterine cancer	0.00501	0.0104	CbGeAlD
Glycine—GLDC—female reproductive system—uterine cancer	0.00497	0.0103	CbGeAlD
Glycine—ALAS1—renal system—uterine cancer	0.00492	0.0102	CbGeAlD
Glycine—GARS—uterine cervix—uterine cancer	0.00479	0.00992	CbGeAlD
Glycine—ALAS1—endometrium—uterine cancer	0.00476	0.00985	CbGeAlD
Glycine—GARS—smooth muscle tissue—uterine cancer	0.00466	0.00964	CbGeAlD
Glycine—ALAS1—mammalian vulva—uterine cancer	0.0046	0.00953	CbGeAlD
Glycine—GARS—decidua—uterine cancer	0.00457	0.00945	CbGeAlD
Glycine—GATM—uterine cervix—uterine cancer	0.00455	0.00941	CbGeAlD
Glycine—GLDC—vagina—uterine cancer	0.00449	0.00929	CbGeAlD
Glycine—GARS—renal system—uterine cancer	0.00448	0.00928	CbGeAlD
Glycine—ALAS1—uterus—uterine cancer	0.00439	0.00907	CbGeAlD
Glycine—GATM—decidua—uterine cancer	0.00433	0.00897	CbGeAlD
Glycine—GARS—endometrium—uterine cancer	0.00433	0.00897	CbGeAlD
Glycine—SLC6A9—lymph node—uterine cancer	0.0043	0.0089	CbGeAlD
Glycine—Lightheadedness—Progesterone—uterine cancer	0.00429	0.0286	CcSEcCtD
Glycine—GATM—renal system—uterine cancer	0.00426	0.00881	CbGeAlD
Glycine—PIPOX—female gonad—uterine cancer	0.00422	0.00873	CbGeAlD
Glycine—PIPOX—vagina—uterine cancer	0.00419	0.00868	CbGeAlD
Glycine—GARS—mammalian vulva—uterine cancer	0.00419	0.00868	CbGeAlD
Glycine—SHMT2—uterine cervix—uterine cancer	0.00417	0.00863	CbGeAlD
Glycine—GCAT—female gonad—uterine cancer	0.00409	0.00847	CbGeAlD
Glycine—GCAT—vagina—uterine cancer	0.00407	0.00842	CbGeAlD
Glycine—Thrombophlebitis—Progesterone—uterine cancer	0.00402	0.0268	CcSEcCtD
Glycine—GARS—uterus—uterine cancer	0.00399	0.00826	CbGeAlD
Glycine—SHMT2—decidua—uterine cancer	0.00397	0.00822	CbGeAlD
Glycine—ALAS1—female reproductive system—uterine cancer	0.00394	0.00816	CbGeAlD
Glycine—GLRB—uterine cervix—uterine cancer	0.00391	0.00808	CbGeAlD
Glycine—SHMT2—renal system—uterine cancer	0.0039	0.00807	CbGeAlD
Glycine—SHMT1—uterine cervix—uterine cancer	0.0038	0.00785	CbGeAlD
Glycine—GATM—uterus—uterine cancer	0.00379	0.00785	CbGeAlD
Glycine—SHMT2—endometrium—uterine cancer	0.00377	0.0078	CbGeAlD
Glycine—GPR18—lymph node—uterine cancer	0.00374	0.00774	CbGeAlD
Glycine—Visual disturbance—Progesterone—uterine cancer	0.00367	0.0245	CcSEcCtD
Glycine—GSS—myometrium—uterine cancer	0.00366	0.00758	CbGeAlD
Glycine—Thirst—Progesterone—uterine cancer	0.00366	0.0244	CcSEcCtD
Glycine—SHMT2—mammalian vulva—uterine cancer	0.00365	0.00755	CbGeAlD
Glycine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00364	0.0243	CcSEcCtD
Glycine—GARS—female reproductive system—uterine cancer	0.00359	0.00743	CbGeAlD
Glycine—ALAS1—female gonad—uterine cancer	0.00359	0.00742	CbGeAlD
Glycine—ALAS1—vagina—uterine cancer	0.00357	0.00738	CbGeAlD
Glycine—SHMT1—renal system—uterine cancer	0.00355	0.00735	CbGeAlD
Glycine—GCSH—lymph node—uterine cancer	0.00351	0.00725	CbGeAlD
Glycine—SHMT2—uterus—uterine cancer	0.00347	0.00719	CbGeAlD
Glycine—SHMT1—endometrium—uterine cancer	0.00343	0.0071	CbGeAlD
Glycine—GATM—female reproductive system—uterine cancer	0.00341	0.00705	CbGeAlD
Glycine—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.0222	CcSEcCtD
Glycine—SHMT1—mammalian vulva—uterine cancer	0.00332	0.00687	CbGeAlD
Glycine—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00331	0.0221	CcSEcCtD
Glycine—GARS—female gonad—uterine cancer	0.00327	0.00676	CbGeAlD
Glycine—GARS—vagina—uterine cancer	0.00325	0.00672	CbGeAlD
Glycine—SHMT2—female reproductive system—uterine cancer	0.00312	0.00646	CbGeAlD
Glycine—GATM—female gonad—uterine cancer	0.0031	0.00642	CbGeAlD
Glycine—GATM—vagina—uterine cancer	0.00308	0.00638	CbGeAlD
Glycine—SLC36A1—renal system—uterine cancer	0.00303	0.00627	CbGeAlD
Glycine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.003	0.02	CcSEcCtD
Glycine—Angina pectoris—Progesterone—uterine cancer	0.00293	0.0195	CcSEcCtD
Glycine—GLDC—lymph node—uterine cancer	0.00291	0.00601	CbGeAlD
Glycine—GSS—uterine cervix—uterine cancer	0.00285	0.0059	CbGeAlD
Glycine—SHMT1—female reproductive system—uterine cancer	0.00284	0.00588	CbGeAlD
Glycine—SHMT2—female gonad—uterine cancer	0.00284	0.00588	CbGeAlD
Glycine—SHMT2—vagina—uterine cancer	0.00282	0.00585	CbGeAlD
Glycine—Cardiovascular disorder—Etoposide—uterine cancer	0.00279	0.0186	CcSEcCtD
Glycine—Pain—Carboplatin—uterine cancer	0.00279	0.0186	CcSEcCtD
Glycine—GSS—smooth muscle tissue—uterine cancer	0.00277	0.00573	CbGeAlD
Glycine—GSS—decidua—uterine cancer	0.00272	0.00562	CbGeAlD
Glycine—SLC36A1—uterus—uterine cancer	0.0027	0.00558	CbGeAlD
Glycine—GSS—renal system—uterine cancer	0.00267	0.00552	CbGeAlD
Glycine—GLRB—vagina—uterine cancer	0.00265	0.00548	CbGeAlD
Glycine—GCAT—lymph node—uterine cancer	0.00263	0.00544	CbGeAlD
Glycine—SHMT1—female gonad—uterine cancer	0.00259	0.00535	CbGeAlD
Glycine—GSS—endometrium—uterine cancer	0.00258	0.00533	CbGeAlD
Glycine—SHMT1—vagina—uterine cancer	0.00257	0.00532	CbGeAlD
Glycine—GSS—mammalian vulva—uterine cancer	0.00249	0.00516	CbGeAlD
Glycine—SLC36A1—female reproductive system—uterine cancer	0.00243	0.00502	CbGeAlD
Glycine—Rhinitis—Progesterone—uterine cancer	0.00241	0.0161	CcSEcCtD
Glycine—GSS—uterus—uterine cancer	0.00238	0.00491	CbGeAlD
Glycine—Visual impairment—Progesterone—uterine cancer	0.00232	0.0155	CcSEcCtD
Glycine—ALAS1—lymph node—uterine cancer	0.00231	0.00477	CbGeAlD
Glycine—GRIN2A—vagina—uterine cancer	0.00221	0.00457	CbGeAlD
Glycine—SLC36A1—female gonad—uterine cancer	0.00221	0.00457	CbGeAlD
Glycine—SLC36A1—vagina—uterine cancer	0.00219	0.00454	CbGeAlD
Glycine—GSS—female reproductive system—uterine cancer	0.00214	0.00442	CbGeAlD
Glycine—SLC16A10—epithelium—uterine cancer	0.00211	0.00436	CbGeAlD
Glycine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.014	CcSEcCtD
Glycine—GARS—lymph node—uterine cancer	0.0021	0.00435	CbGeAlD
Glycine—Back pain—Progesterone—uterine cancer	0.00203	0.0135	CcSEcCtD
Glycine—GATM—lymph node—uterine cancer	0.00199	0.00413	CbGeAlD
Glycine—Vision blurred—Progesterone—uterine cancer	0.00198	0.0132	CcSEcCtD
Glycine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.0131	CcSEcCtD
Glycine—GSS—female gonad—uterine cancer	0.00194	0.00402	CbGeAlD
Glycine—Lung disorder—Epirubicin—uterine cancer	0.00194	0.013	CcSEcCtD
Glycine—GSS—vagina—uterine cancer	0.00193	0.004	CbGeAlD
Glycine—Vertigo—Progesterone—uterine cancer	0.00188	0.0126	CcSEcCtD
Glycine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.0123	CcSEcCtD
Glycine—SHMT2—lymph node—uterine cancer	0.00183	0.00378	CbGeAlD
Glycine—SLC16A10—mammalian vulva—uterine cancer	0.00183	0.00378	CbGeAlD
Glycine—Convulsion—Progesterone—uterine cancer	0.00182	0.0121	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—uterine cancer	0.0018	0.012	CcSEcCtD
Glycine—GLRB—lymph node—uterine cancer	0.00171	0.00354	CbGeAlD
Glycine—Oedema—Progesterone—uterine cancer	0.00171	0.0114	CcSEcCtD
Glycine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.0114	CcSEcCtD
Glycine—Tachycardia—Progesterone—uterine cancer	0.00167	0.0111	CcSEcCtD
Glycine—SHMT1—lymph node—uterine cancer	0.00166	0.00344	CbGeAlD
Glycine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.011	CcSEcCtD
Glycine—Hypotension—Progesterone—uterine cancer	0.0016	0.0107	CcSEcCtD
Glycine—Cardiovascular disorder—Epirubicin—uterine cancer	0.00157	0.0104	CcSEcCtD
Glycine—SLC16A10—female reproductive system—uterine cancer	0.00156	0.00324	CbGeAlD
Glycine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0103	CcSEcCtD
Glycine—Chills—Dactinomycin—uterine cancer	0.00153	0.0102	CcSEcCtD
Glycine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.0101	CcSEcCtD
Glycine—Pain—Progesterone—uterine cancer	0.00146	0.00976	CcSEcCtD
Glycine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00966	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00145	0.00966	CcSEcCtD
Glycine—SLC36A1—lymph node—uterine cancer	0.00142	0.00294	CbGeAlD
Glycine—SLC16A10—vagina—uterine cancer	0.00141	0.00293	CbGeAlD
Glycine—Urticaria—Progesterone—uterine cancer	0.00136	0.00906	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—uterine cancer	0.00134	0.00891	CcSEcCtD
Glycine—Hypersensitivity—Progesterone—uterine cancer	0.00126	0.00841	CcSEcCtD
Glycine—Coma—Epirubicin—uterine cancer	0.00126	0.00838	CcSEcCtD
Glycine—GSS—lymph node—uterine cancer	0.00125	0.00258	CbGeAlD
Glycine—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00124	0.00824	CcSEcCtD
Glycine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00821	CcSEcCtD
Glycine—Oedema—Dactinomycin—uterine cancer	0.00121	0.00806	CcSEcCtD
Glycine—Diarrhoea—Progesterone—uterine cancer	0.00117	0.00781	CcSEcCtD
Glycine—Coma—Doxorubicin—uterine cancer	0.00116	0.00775	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—uterine cancer	0.00115	0.00769	CcSEcCtD
Glycine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00762	CcSEcCtD
Glycine—Dizziness—Progesterone—uterine cancer	0.00113	0.00754	CcSEcCtD
Glycine—Chills—Etoposide—uterine cancer	0.00111	0.00737	CcSEcCtD
Glycine—Vomiting—Progesterone—uterine cancer	0.00109	0.00725	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—uterine cancer	0.00107	0.00711	CcSEcCtD
Glycine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00707	CcSEcCtD
Glycine—Back pain—Etoposide—uterine cancer	0.00104	0.00692	CcSEcCtD
Glycine—Pain—Dactinomycin—uterine cancer	0.00103	0.0069	CcSEcCtD
Glycine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00684	CcSEcCtD
Glycine—Nausea—Progesterone—uterine cancer	0.00102	0.00678	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—uterine cancer	0.001	0.00668	CcSEcCtD
Glycine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000986	0.00657	CcSEcCtD
Glycine—Vertigo—Etoposide—uterine cancer	0.000964	0.00642	CcSEcCtD
Glycine—Convulsion—Etoposide—uterine cancer	0.000929	0.0062	CcSEcCtD
Glycine—Dehydration—Epirubicin—uterine cancer	0.000928	0.00619	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—uterine cancer	0.000927	0.00618	CcSEcCtD
Glycine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000921	0.00614	CcSEcCtD
Glycine—SLC16A10—lymph node—uterine cancer	0.000915	0.00189	CbGeAlD
Glycine—Hypersensitivity—Dactinomycin—uterine cancer	0.000891	0.00594	CcSEcCtD
Glycine—Dehydration—Doxorubicin—uterine cancer	0.000859	0.00573	CcSEcCtD
Glycine—Tachycardia—Etoposide—uterine cancer	0.000854	0.0057	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—uterine cancer	0.00084	0.0056	CcSEcCtD
Glycine—Diarrhoea—Dactinomycin—uterine cancer	0.000827	0.00552	CcSEcCtD
Glycine—Hypotension—Etoposide—uterine cancer	0.000818	0.00545	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—uterine cancer	0.000778	0.00519	CcSEcCtD
Glycine—Vomiting—Dactinomycin—uterine cancer	0.000769	0.00513	CcSEcCtD
Glycine—Pain—Etoposide—uterine cancer	0.000748	0.00499	CcSEcCtD
Glycine—Nausea—Dactinomycin—uterine cancer	0.000718	0.00479	CcSEcCtD
Glycine—Urticaria—Etoposide—uterine cancer	0.000695	0.00464	CcSEcCtD
Glycine—Rhinitis—Epirubicin—uterine cancer	0.000692	0.00462	CcSEcCtD
Glycine—Visual impairment—Epirubicin—uterine cancer	0.000666	0.00444	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—uterine cancer	0.000645	0.0043	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—uterine cancer	0.000641	0.00427	CcSEcCtD
Glycine—Chills—Epirubicin—uterine cancer	0.00062	0.00413	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—uterine cancer	0.000616	0.00411	CcSEcCtD
Glycine—Diarrhoea—Etoposide—uterine cancer	0.000599	0.00399	CcSEcCtD
Glycine—Back pain—Epirubicin—uterine cancer	0.000581	0.00388	CcSEcCtD
Glycine—Dizziness—Etoposide—uterine cancer	0.000579	0.00386	CcSEcCtD
Glycine—Chills—Doxorubicin—uterine cancer	0.000573	0.00382	CcSEcCtD
Glycine—GRIN2A—Reelin signaling pathway—AKT1—uterine cancer	0.000571	0.00161	CbGpPWpGaD
Glycine—GARS—Gene Expression—PGR—uterine cancer	0.00057	0.00161	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—CXCL8—uterine cancer	0.000569	0.0016	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—uterine cancer	0.000568	0.0016	CbGpPWpGaD
Glycine—Vision blurred—Epirubicin—uterine cancer	0.000567	0.00378	CcSEcCtD
Glycine—Vomiting—Etoposide—uterine cancer	0.000557	0.00371	CcSEcCtD
Glycine—GPR18—Signaling Pathways—AKR1B10—uterine cancer	0.000549	0.00155	CbGpPWpGaD
Glycine—GARS—Gene Expression—EZH2—uterine cancer	0.000542	0.00153	CbGpPWpGaD
Glycine—Vertigo—Epirubicin—uterine cancer	0.00054	0.0036	CcSEcCtD
Glycine—Back pain—Doxorubicin—uterine cancer	0.000538	0.00359	CcSEcCtD
Glycine—ALAS2—Metabolism—RRM2—uterine cancer	0.000527	0.00148	CbGpPWpGaD
Glycine—Vision blurred—Doxorubicin—uterine cancer	0.000524	0.0035	CcSEcCtD
Glycine—Convulsion—Epirubicin—uterine cancer	0.000521	0.00347	CcSEcCtD
Glycine—Nausea—Etoposide—uterine cancer	0.00052	0.00347	CcSEcCtD
Glycine—AGXT—Metabolism—STAR—uterine cancer	0.000519	0.00146	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKR1B1—uterine cancer	0.000519	0.00146	CbGpPWpGaD
Glycine—GRIN2A—Post NMDA receptor activation events—HRAS—uterine cancer	0.000517	0.00146	CbGpPWpGaD
Glycine—ALAS2—Metabolism—DCN—uterine cancer	0.000511	0.00144	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKR1B1—uterine cancer	0.000502	0.00142	CbGpPWpGaD
Glycine—ALAS1—Metabolism—STAR—uterine cancer	0.000502	0.00142	CbGpPWpGaD
Glycine—GARS—Gene Expression—ESR2—uterine cancer	0.000502	0.00141	CbGpPWpGaD
Glycine—Vertigo—Doxorubicin—uterine cancer	0.0005	0.00333	CcSEcCtD
Glycine—SHMT1—Metabolism—SRD5A2—uterine cancer	0.000497	0.0014	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NDUFB11—uterine cancer	0.000497	0.0014	CbGpPWpGaD
Glycine—ALAS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000497	0.0014	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000497	0.0014	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—uterine cancer	0.000492	0.00139	CbGpPWpGaD
Glycine—Oedema—Epirubicin—uterine cancer	0.000491	0.00327	CcSEcCtD
Glycine—GSS—Metabolism—SRD5A2—uterine cancer	0.000485	0.00137	CbGpPWpGaD
Glycine—GSS—Metabolism—NDUFB11—uterine cancer	0.000485	0.00137	CbGpPWpGaD
Glycine—Convulsion—Doxorubicin—uterine cancer	0.000482	0.00321	CcSEcCtD
Glycine—ALAS2—Metabolism—CYP11A1—uterine cancer	0.000482	0.00136	CbGpPWpGaD
Glycine—Tachycardia—Epirubicin—uterine cancer	0.000479	0.00319	CcSEcCtD
Glycine—GLYATL2—Metabolism—POLD1—uterine cancer	0.000479	0.00135	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POLD1—uterine cancer	0.000479	0.00135	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POLD1—uterine cancer	0.000479	0.00135	CbGpPWpGaD
Glycine—GATM—Metabolism—POLD1—uterine cancer	0.000479	0.00135	CbGpPWpGaD
Glycine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—uterine cancer	0.000477	0.00134	CbGpPWpGaD
Glycine—SHMT1—Disease—AKR1B10—uterine cancer	0.000462	0.0013	CbGpPWpGaD
Glycine—Hypotension—Epirubicin—uterine cancer	0.000458	0.00306	CcSEcCtD
Glycine—BAAT—Metabolism—POLD1—uterine cancer	0.000457	0.00129	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKR1C3—uterine cancer	0.000455	0.00128	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RNF43—uterine cancer	0.000455	0.00128	CbGpPWpGaD
Glycine—Oedema—Doxorubicin—uterine cancer	0.000454	0.00303	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000452	0.00127	CbGpPWpGaD
Glycine—GATM—Metabolism—AKR1C1—uterine cancer	0.000448	0.00126	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKR1C1—uterine cancer	0.000448	0.00126	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKR1C1—uterine cancer	0.000448	0.00126	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKR1C1—uterine cancer	0.000448	0.00126	CbGpPWpGaD
Glycine—Tachycardia—Doxorubicin—uterine cancer	0.000443	0.00295	CcSEcCtD
Glycine—AGXT2—Metabolism—AKR1B1—uterine cancer	0.000441	0.00124	CbGpPWpGaD
Glycine—AGXT2—Metabolism—STAR—uterine cancer	0.000441	0.00124	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCL2—uterine cancer	0.000436	0.00123	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000434	0.00122	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKR1C1—uterine cancer	0.000427	0.0012	CbGpPWpGaD
Glycine—Hypotension—Doxorubicin—uterine cancer	0.000424	0.00283	CcSEcCtD
Glycine—Pain—Epirubicin—uterine cancer	0.00042	0.0028	CcSEcCtD
Glycine—GPR18—Signaling Pathways—INHBA—uterine cancer	0.000416	0.00117	CbGpPWpGaD
Glycine—GARS—Gene Expression—CDKN2B—uterine cancer	0.000409	0.00115	CbGpPWpGaD
Glycine—AGXT—Metabolism—POLD1—uterine cancer	0.000407	0.00115	CbGpPWpGaD
Glycine—GLYAT—Metabolism—RRM2—uterine cancer	0.000399	0.00113	CbGpPWpGaD
Glycine—GATM—Metabolism—RRM2—uterine cancer	0.000399	0.00113	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—RRM2—uterine cancer	0.000399	0.00113	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—RRM2—uterine cancer	0.000399	0.00113	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POLD1—uterine cancer	0.000394	0.00111	CbGpPWpGaD
Glycine—Urticaria—Epirubicin—uterine cancer	0.00039	0.0026	CcSEcCtD
Glycine—Pain—Doxorubicin—uterine cancer	0.000388	0.00259	CcSEcCtD
Glycine—GLYAT—Metabolism—DCN—uterine cancer	0.000388	0.00109	CbGpPWpGaD
Glycine—GATM—Metabolism—DCN—uterine cancer	0.000388	0.00109	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—DCN—uterine cancer	0.000388	0.00109	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—DCN—uterine cancer	0.000388	0.00109	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—uterine cancer	0.000386	0.00109	CbGpPWpGaD
Glycine—SHMT1—Disease—RNF43—uterine cancer	0.000383	0.00108	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKR1C1—uterine cancer	0.000381	0.00107	CbGpPWpGaD
Glycine—BAAT—Metabolism—RRM2—uterine cancer	0.000381	0.00107	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKR1C1—uterine cancer	0.000374	0.00106	CbGpPWpGaD
Glycine—GARS—Gene Expression—SMAD3—uterine cancer	0.000373	0.00105	CbGpPWpGaD
Glycine—BAAT—Metabolism—DCN—uterine cancer	0.00037	0.00104	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKR1C1—uterine cancer	0.000369	0.00104	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP11A1—uterine cancer	0.000365	0.00103	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP11A1—uterine cancer	0.000365	0.00103	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CYP11A1—uterine cancer	0.000365	0.00103	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP11A1—uterine cancer	0.000365	0.00103	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000362	0.00102	CbGpPWpGaD
Glycine—Hypersensitivity—Epirubicin—uterine cancer	0.000361	0.00241	CcSEcCtD
Glycine—Urticaria—Doxorubicin—uterine cancer	0.000361	0.0024	CcSEcCtD
Glycine—SHMT1—Metabolism—STAR—uterine cancer	0.00036	0.00101	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKR1B1—uterine cancer	0.00036	0.00101	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CYP19A1—uterine cancer	0.000354	0.000999	CbGpPWpGaD
Glycine—ALAS2—Metabolism—STK11—uterine cancer	0.000354	0.000999	CbGpPWpGaD
Glycine—GSS—Metabolism—STAR—uterine cancer	0.00035	0.000988	CbGpPWpGaD
Glycine—GSS—Metabolism—AKR1B1—uterine cancer	0.00035	0.000988	CbGpPWpGaD
Glycine—BAAT—Metabolism—CYP11A1—uterine cancer	0.000348	0.000982	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POLD1—uterine cancer	0.000346	0.000976	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKR1C3—uterine cancer	0.000345	0.000972	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKR1C3—uterine cancer	0.000345	0.000972	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKR1C3—uterine cancer	0.000345	0.000972	CbGpPWpGaD
Glycine—GATM—Metabolism—AKR1C3—uterine cancer	0.000345	0.000972	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CXCL8—uterine cancer	0.000344	0.000971	CbGpPWpGaD
Glycine—AGXT—Metabolism—RRM2—uterine cancer	0.000339	0.000957	CbGpPWpGaD
Glycine—Diarrhoea—Epirubicin—uterine cancer	0.000336	0.00224	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—uterine cancer	0.000334	0.00223	CcSEcCtD
Glycine—AGXT—Metabolism—DCN—uterine cancer	0.000329	0.000929	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKR1C3—uterine cancer	0.000329	0.000927	CbGpPWpGaD
Glycine—ALAS1—Metabolism—RRM2—uterine cancer	0.000329	0.000926	CbGpPWpGaD
Glycine—Dizziness—Epirubicin—uterine cancer	0.000324	0.00216	CcSEcCtD
Glycine—AGXT2—Metabolism—AKR1C1—uterine cancer	0.000324	0.000913	CbGpPWpGaD
Glycine—ALAS1—Metabolism—DCN—uterine cancer	0.000319	0.000899	CbGpPWpGaD
Glycine—SHMT1—Disease—AKR1C1—uterine cancer	0.000315	0.000888	CbGpPWpGaD
Glycine—Vomiting—Epirubicin—uterine cancer	0.000312	0.00208	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—uterine cancer	0.000311	0.00207	CcSEcCtD
Glycine—AGXT—Metabolism—CYP11A1—uterine cancer	0.00031	0.000875	CbGpPWpGaD
Glycine—GARS—Gene Expression—ESR1—uterine cancer	0.000304	0.000858	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP11A1—uterine cancer	0.000301	0.000847	CbGpPWpGaD
Glycine—Dizziness—Doxorubicin—uterine cancer	0.0003	0.002	CcSEcCtD
Glycine—GRIN2A—Alzheimers Disease—TP53—uterine cancer	0.000295	0.000831	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKR1C3—uterine cancer	0.000293	0.000826	CbGpPWpGaD
Glycine—Nausea—Epirubicin—uterine cancer	0.000291	0.00194	CcSEcCtD
Glycine—Vomiting—Doxorubicin—uterine cancer	0.000289	0.00192	CcSEcCtD
Glycine—AGXT2—Metabolism—RRM2—uterine cancer	0.000289	0.000813	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKR1C3—uterine cancer	0.000288	0.000813	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKR1C3—uterine cancer	0.000284	0.0008	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POLD1—uterine cancer	0.000282	0.000795	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PGR—uterine cancer	0.000281	0.000792	CbGpPWpGaD
Glycine—AGXT2—Metabolism—DCN—uterine cancer	0.00028	0.00079	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—uterine cancer	0.000278	0.000783	CbGpPWpGaD
Glycine—GSS—Metabolism—POLD1—uterine cancer	0.000275	0.000775	CbGpPWpGaD
Glycine—SHMT1—Disease—DCN—uterine cancer	0.000273	0.000769	CbGpPWpGaD
Glycine—Nausea—Doxorubicin—uterine cancer	0.00027	0.0018	CcSEcCtD
Glycine—GATM—Metabolism—STK11—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—STK11—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—STK11—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GLYAT—Metabolism—STK11—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CYP19A1—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP19A1—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP19A1—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP19A1—uterine cancer	0.000269	0.000757	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—YWHAE—uterine cancer	0.000268	0.000755	CbGpPWpGaD
Glycine—ALAS2—Metabolism—MTHFR—uterine cancer	0.000266	0.000751	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP11A1—uterine cancer	0.000264	0.000744	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKR1C1—uterine cancer	0.000264	0.000744	CbGpPWpGaD
Glycine—GSS—Metabolism—AKR1C1—uterine cancer	0.000257	0.000725	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FBXW7—uterine cancer	0.000257	0.000724	CbGpPWpGaD
Glycine—BAAT—Metabolism—CYP19A1—uterine cancer	0.000256	0.000722	CbGpPWpGaD
Glycine—BAAT—Metabolism—STK11—uterine cancer	0.000256	0.000722	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKR1C3—uterine cancer	0.000249	0.000703	CbGpPWpGaD
Glycine—SHMT1—Disease—AKR1C3—uterine cancer	0.000243	0.000684	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000241	0.000678	CbGpPWpGaD
Glycine—SHMT1—Disease—HMGA1—uterine cancer	0.000236	0.000666	CbGpPWpGaD
Glycine—SHMT1—Metabolism—RRM2—uterine cancer	0.000235	0.000663	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	0.000234	0.000659	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000229	0.000647	CbGpPWpGaD
Glycine—GSS—Metabolism—RRM2—uterine cancer	0.000229	0.000646	CbGpPWpGaD
Glycine—AGXT—Metabolism—STK11—uterine cancer	0.000228	0.000644	CbGpPWpGaD
Glycine—AGXT—Metabolism—CYP19A1—uterine cancer	0.000228	0.000644	CbGpPWpGaD
Glycine—SHMT1—Metabolism—DCN—uterine cancer	0.000228	0.000644	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STK11—uterine cancer	0.000225	0.000633	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL2—uterine cancer	0.000224	0.00063	CbGpPWpGaD
Glycine—GSS—Metabolism—DCN—uterine cancer	0.000223	0.000627	CbGpPWpGaD
Glycine—ALAS1—Metabolism—STK11—uterine cancer	0.000221	0.000623	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP19A1—uterine cancer	0.000221	0.000623	CbGpPWpGaD
Glycine—SHMT1—Disease—FBXW7—uterine cancer	0.000216	0.00061	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP11A1—uterine cancer	0.000215	0.000606	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SOCS3—uterine cancer	0.00021	0.000593	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP11A1—uterine cancer	0.00021	0.000591	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000208	0.000585	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKR1C3—uterine cancer	0.000203	0.000573	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—MTHFR—uterine cancer	0.000202	0.000569	CbGpPWpGaD
Glycine—GATM—Metabolism—MTHFR—uterine cancer	0.000202	0.000569	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—MTHFR—uterine cancer	0.000202	0.000569	CbGpPWpGaD
Glycine—GLYAT—Metabolism—MTHFR—uterine cancer	0.000202	0.000569	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN2B—uterine cancer	0.000201	0.000567	CbGpPWpGaD
Glycine—GSS—Metabolism—AKR1C3—uterine cancer	0.000198	0.000558	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000198	0.000558	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1R—uterine cancer	0.000196	0.000551	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL8—uterine cancer	0.000195	0.000549	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP19A1—uterine cancer	0.000194	0.000547	CbGpPWpGaD
Glycine—AGXT2—Metabolism—STK11—uterine cancer	0.000194	0.000547	CbGpPWpGaD
Glycine—BAAT—Metabolism—MTHFR—uterine cancer	0.000193	0.000543	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SMAD3—uterine cancer	0.000184	0.000518	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	0.000178	0.000503	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL8—uterine cancer	0.000177	0.000498	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000176	0.000495	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR2—uterine cancer	0.000175	0.000494	CbGpPWpGaD
Glycine—AGXT—Metabolism—MTHFR—uterine cancer	0.000172	0.000484	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.00017	0.000478	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN2B—uterine cancer	0.000169	0.000478	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—uterine cancer	0.000166	0.000468	CbGpPWpGaD
Glycine—SHMT1—Metabolism—STK11—uterine cancer	0.000158	0.000446	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP19A1—uterine cancer	0.000158	0.000446	CbGpPWpGaD
Glycine—SHMT1—Disease—SMAD3—uterine cancer	0.000155	0.000436	CbGpPWpGaD
Glycine—GSS—Metabolism—STK11—uterine cancer	0.000154	0.000435	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP19A1—uterine cancer	0.000154	0.000435	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—uterine cancer	0.00015	0.000423	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—uterine cancer	0.000148	0.000418	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR2—uterine cancer	0.000148	0.000416	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000146	0.000413	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—uterine cancer	0.000146	0.000411	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—uterine cancer	0.000142	0.0004	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—uterine cancer	0.000142	0.0004	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—uterine cancer	0.000141	0.000398	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—uterine cancer	0.000135	0.000379	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000134	0.000378	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—uterine cancer	0.000132	0.000372	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—uterine cancer	0.000123	0.000348	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—uterine cancer	0.000122	0.000344	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—uterine cancer	0.000119	0.000335	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—uterine cancer	0.000116	0.000327	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—uterine cancer	0.000112	0.000316	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—uterine cancer	0.000112	0.000316	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—uterine cancer	0.000112	0.000316	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—uterine cancer	0.000112	0.000316	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—uterine cancer	0.000112	0.000316	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—uterine cancer	0.00011	0.00031	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—uterine cancer	0.00011	0.000309	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—uterine cancer	0.000107	0.000302	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—uterine cancer	0.000107	0.000302	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—uterine cancer	0.000107	0.000302	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—uterine cancer	0.000107	0.000302	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—uterine cancer	0.000107	0.000302	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—uterine cancer	0.000105	0.000295	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—uterine cancer	0.000104	0.000294	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—uterine cancer	0.000104	0.000292	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—uterine cancer	0.000103	0.00029	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—uterine cancer	0.000102	0.000288	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—uterine cancer	0.000102	0.000287	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—uterine cancer	0.000101	0.000284	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—uterine cancer	9.63e-05	0.000272	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—uterine cancer	9.55e-05	0.000269	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—uterine cancer	9.39e-05	0.000265	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—uterine cancer	9.27e-05	0.000261	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—uterine cancer	9.25e-05	0.000261	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—uterine cancer	9.16e-05	0.000258	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—uterine cancer	9.11e-05	0.000257	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—uterine cancer	8.95e-05	0.000252	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—uterine cancer	8.82e-05	0.000249	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—uterine cancer	8.58e-05	0.000242	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—uterine cancer	8.54e-05	0.000241	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—uterine cancer	8.48e-05	0.000239	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—uterine cancer	8.38e-05	0.000236	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—uterine cancer	8.12e-05	0.000229	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—uterine cancer	8.11e-05	0.000229	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—uterine cancer	7.92e-05	0.000223	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—uterine cancer	7.92e-05	0.000223	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—uterine cancer	7.92e-05	0.000223	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—uterine cancer	7.92e-05	0.000223	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—uterine cancer	7.9e-05	0.000223	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—uterine cancer	7.74e-05	0.000218	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—uterine cancer	7.56e-05	0.000213	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—uterine cancer	7.54e-05	0.000212	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—uterine cancer	7.21e-05	0.000203	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—uterine cancer	7.05e-05	0.000199	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—uterine cancer	6.74e-05	0.00019	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—uterine cancer	6.62e-05	0.000187	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—uterine cancer	6.62e-05	0.000187	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—uterine cancer	6.52e-05	0.000184	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—uterine cancer	6.47e-05	0.000182	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—uterine cancer	6.47e-05	0.000182	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—uterine cancer	6.47e-05	0.000182	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—uterine cancer	6.47e-05	0.000182	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—uterine cancer	6.45e-05	0.000182	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—uterine cancer	6.41e-05	0.000181	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—uterine cancer	6.31e-05	0.000178	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—uterine cancer	6.17e-05	0.000174	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—uterine cancer	6.15e-05	0.000173	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—uterine cancer	6.13e-05	0.000173	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—uterine cancer	6.07e-05	0.000171	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—uterine cancer	5.73e-05	0.000161	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—uterine cancer	5.57e-05	0.000157	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—uterine cancer	5.5e-05	0.000155	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—uterine cancer	5.41e-05	0.000153	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—uterine cancer	5.33e-05	0.00015	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—uterine cancer	5.16e-05	0.000145	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—uterine cancer	4.68e-05	0.000132	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—uterine cancer	4.67e-05	0.000132	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—uterine cancer	4.55e-05	0.000128	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—uterine cancer	4.55e-05	0.000128	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—uterine cancer	3.81e-05	0.000107	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—uterine cancer	3.72e-05	0.000105	CbGpPWpGaD
